Nursing and Health Professions
Systematic Review
100%
Health Care Personnel
74%
Mental Health
65%
Disease
55%
Palliative Therapy
55%
Practice Guideline
48%
Quality of Life
45%
Malignant Neoplasm
43%
Health Service
40%
Physician
40%
Clinical Practice
34%
Health Practitioner
34%
Injury
33%
Prevalence
32%
Intellectual Disability
31%
Meta Analysis
31%
Cerebrovascular Accident
29%
Pandemic
27%
Midwife
25%
Thematic Analysis
25%
Cross-Sectional Study
24%
Intellectual Impairment
24%
Nutrition Policy
24%
Self Care
22%
Hospital
22%
Occupation (Patient Social Context)
21%
Learning Disorder
20%
Nursing Student
20%
Drug Therapy
19%
Diagnosis
19%
Home Care
19%
Adolescent
19%
Confidence Interval
18%
Physiotherapy
18%
Radiographer
18%
Patient Referral
18%
Primary Medical Care
17%
Client
17%
Non Insulin Dependent Diabetes Mellitus
17%
Pilot Study
17%
Base
16%
Athletes
16%
General Practitioner
16%
CINAHL
16%
Patient Care
16%
Nursing Home
16%
Medline
15%
World Health Organization
15%
Accelerometer
15%
Literature Review
15%
Radiotherapy
14%
Low Back Pain
14%
Ward
13%
Lived Experience
13%
Body Mass
13%
Head and Neck Cancer
13%
Radiation Therapist
13%
Longitudinal Analysis
13%
Clinical Audit
13%
Artificial Intelligence
13%
Cohort Analysis
13%
Psychometry
12%
Breast Cancer
12%
Electrocardiogram
12%
Self-Efficacy
12%
Supplementation
12%
Prostate Cancer
12%
Emergency Care
11%
Fibromyalgia
11%
Refraction Error
11%
Nursing Practice
11%
Ankle Sprain
11%
Obesity
11%
Syndrome
10%
Diabetes Mellitus
10%
Content Analysis
10%
Cerebral Palsy
10%
Cost Effectiveness Analysis
10%
Analgesia
10%
Intensive Care Unit
10%
Physiotherapist
9%
Infection
9%
Volunteer
9%
Cardiovascular Disease
9%
Self Report
9%
Checklist
9%
End of Life Care
9%
Analysis of Variance
9%
Intensive Care
8%
Professional Standard
8%
Social Support
8%
Logistic Regression Analysis
8%
Biological Marker
8%
Emergency Ward
8%
Registered Nurse
8%
Wound
8%
Advance Care Planning
8%
Socialized Medicine
8%
Health Outcomes
8%
Long Term Care
7%
Medicine and Dentistry
Systematic Review
83%
Disease
73%
Diabetes
53%
Physical Activity
50%
Randomized Controlled Trial
49%
Mental Health
47%
COVID-19
42%
Congenital Malformation
38%
Malignant Neoplasm
35%
Maturity Onset Diabetes of the Young
35%
Prevalence
35%
Meta-Analysis
33%
Symptomatic Treatment
33%
Gastric Inhibitory Polypeptide
32%
Injury
28%
In Vitro
28%
Quality of Life
28%
Nutrition
27%
Biological Marker
27%
Beta Cell
27%
Cross Sectional Study
25%
Diagnosis
24%
Glucagon Like Peptide 1
24%
Insulin Release
23%
Health Care Cost
23%
Drug Therapy
22%
Public Health
22%
Clinician
21%
Prostate Cancer
20%
Receptor
19%
Infection
18%
Neoplasm
18%
Diabetes Mellitus
17%
Breast Cancer
17%
Pancreatic Islet
16%
Cohort Analysis
16%
Health Care
16%
Awareness
16%
Radiographer
16%
Attitude
14%
Supplementation
14%
Bariatric Surgery
14%
Adolescence
14%
Health Outcomes
13%
Placebo
13%
Clinical Trial
13%
Apoplexy
13%
Antidiabetic Agent
13%
Cardiovascular Disease
13%
Persistent Truncus Arteriosus
13%
Primary Health Care
12%
Medicine
12%
Radiation Therapy
12%
Antioxidant
12%
Body Mass Index
12%
Pediatrics
12%
Observational Study
12%
Cell Line
11%
Refractive Error
11%
Head and Neck Cancer
11%
Odds Ratio
11%
Cell Function
11%
Wellbeing
11%
Gut
11%
Incretin
11%
Glucose Tolerance
11%
Patient Referral
11%
Decision Making
11%
Down Syndrome
10%
Gene Linkage
10%
Spastic Diplegia
10%
Behavioral Change
10%
Intellectual Disability
10%
Calcium Ion
10%
Oxidative Stress
10%
Consultation
9%
Ankle Sprain
9%
Lung
9%
Glucagon
9%
Gene Expression
9%
Hip
9%
Low and Middle Income Countries
9%
Comorbidity
9%
Obesity
9%
Vitamin D
9%
Obstetrics
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Streptozocin
9%
Hyperglycemia
9%
Visual Acuity
8%
Insulin Dependent Diabetes Mellitus
8%
Body Weight
8%
Interstitial Lung Disease
8%
Case-Control Study
8%
Patient Care
8%
Antidiabetic Activity
8%
Programmed Cell Death
8%
Arm
8%
Personal Experience
7%
Hypoxia
7%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
75%
Gastric Inhibitory Polypeptide
40%
Malignant Neoplasm
39%
Neoplasm
36%
Non Insulin Dependent Diabetes Mellitus
34%
Glucagon-Like Peptide-1
32%
Prevalence
31%
Biological Marker
30%
Antiinfective Agent
30%
Antidiabetic Agent
29%
Infection
27%
Receptor
26%
Inflammation
25%
Anura
24%
Randomized Controlled Trial
24%
Biosurfactant
24%
Antioxidant
23%
Diabetes Mellitus
22%
Amino Acid
20%
Congenital Malformation
20%
Nanoparticle
19%
Prostate Cancer
19%
Placebo
18%
Antibiotics
15%
Folic Acid
15%
Drug Delivery System
15%
Vitamin D
15%
Injury
14%
Clinical Trial
14%
Cross-Sectional Study
14%
Cytokine
14%
Cardiovascular Disease
13%
Side Effect
13%
Breast Cancer
13%
Cytotoxicity
12%
Infectious Agent
12%
Alzheimer's Disease
12%
Microorganism
12%
Arginine
12%
Salmonine
12%
Transdermal
12%
Antimicrobial Agent
12%
Incretin
12%
Streptozotocin
12%
HIV
11%
Ob/Ob Mouse
11%
Normal Human
10%
Cohort Study
10%
Biological Activity
10%
SARS Coronavirus
10%
Surfactant
10%
Pharmacotherapy
9%
Adverse Event
9%
Colorectal Carcinoma
9%
Substance P
9%
Hypoxia
9%
Pandemic
9%
Homocysteine
9%
Diabetic Obesity
9%
Pseudomonas aeruginosa
9%
Antibiotic Resistance
9%
Gastric Inhibitory Polypeptide Receptor
9%
Comet Assay
9%
Observational Study
9%
Ethanol
9%
Amyotrophic Lateral Sclerosis
8%
Transdermal Delivery
8%
Combination Therapy
8%
Exendin 4
8%
Pharmacokinetics
8%
Rhamnolipid
8%
Dipeptidyl Peptidase IV
8%
Tachykinin
8%
Bioavailability
8%
Staphylococcus Aureus
8%
Mouse Model
8%
Photodynamic Therapy
8%
Liraglutide
8%
Tumor Necrosis Factor
7%
Coronavirinae
7%
Polyphenol
7%
Methylmercury
7%
Obesity
7%
Comorbidity
7%
Pancreas Cancer
7%
Polypeptide Antibiotic Agent
7%
Calcium Ion
7%
Cell Viability
7%
Escherichia coli
7%
Bradykinin
7%
Fatty Acid
7%
Insulin Dependent Diabetes Mellitus
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Messenger RNA
7%
Colon Carcinoma
7%
Drug Release
7%
Adenosine Triphosphate
7%
Wound
6%
Oncorhynchus mykiss
6%
Carboxamide
6%